Oncology & Cancer

Experimental drug may boost leukemia survival, without chemo

(HealthDay)—An experimental drug may extend the lives of people with certain hard-to-treat forms of leukemia and lymphoma—without the need for traditional chemotherapy, according to two studies released Wednesday.

Oncology & Cancer

Study yields new strategy against high-risk leukemia

August 29, 2013) St. Jude Children's Research Hospital scientists have identified a protein that certain high-risk acute lymphoblastic leukemia (ALL) cells need to survive and have used that knowledge to fashion a more effective ...

Oncology & Cancer

Pazopanib shows better quality-of-life in advanced kidney cancer

Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer ...

HIV & AIDS

Plant-based compound may inhibit HIV

A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers.

Oncology & Cancer

Alternative target for breast cancer drugs

Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

page 12 from 17